ArticleNeuropsychiatric disease and treatment2015

Milnacipran treatment and potential biomarkers in depressed patients following an initial SSRI treatment failure: a prospective, open-label, 24-week study.

Tasuku Hashimoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.